bf/NASDAQ:RDHL_icon.jpeg

NASDAQ:RDHL

RedHill Biopharma Ltd.

  • Stock

USD

Last Close

8.15

08/11 21:00

Market Cap

11.60M

Beta: 2.16

Volume Today

8.87K

Avg: 100.31K

PE Ratio

−0.19

PFCF: −0.39

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-658.50K
-
-7.70M
1,070.01%
-24.76M
221.33%
-16.68M
32.63%
883.50K
105.30%
711K
19.52%
1.33M
86.43%
4.20M
217.16%
10.67M
153.76%
12.91M
21.01%
8.35M
35.29%
average payables
597.50K
-
1.30M
117.74%
2.62M
101.15%
3.44M
31.26%
4.08M
18.79%
4.06M
0.39%
3.75M
7.64%
7.87M
109.60%
11.61M
47.53%
7.95M
31.54%
3.75M
52.76%
average receivables
255.50K
-
745.50K
191.78%
642K
13.88%
356K
44.55%
1.01M
183.71%
1.24M
23.07%
1.09M
12.55%
14.94M
1,274.01%
30.59M
104.81%
33.94M
10.95%
19.32M
43.08%
book value per share
76.47
-
115.51
51.06%
216.86
87.74%
196.41
9.43%
102.91
47.61%
89.66
12.87%
79.43
11.41%
14.44
81.82%
7.63
47.17%
-31.26
509.72%
0.32
101.02%
capex per share
-1.44
-
-5.10
255.29%
-5.90
15.57%
-0.38
93.63%
-2.70
617.44%
-0.10
96.23%
-0.27
164.50%
-56.02
20,745.87%
-0.10
99.82%
-0.13
29.35%
-0.00
98.68%
capex to depreciation
-9.33
-
-40.93
338.49%
-45.39
10.90%
-2.73
93.99%
-14.58
434.61%
-0.64
95.58%
-0.17
74.03%
-6.15
3,574.32%
-0.01
99.90%
-0.02
283.22%
-0.01
77.24%
capex to operating cash flow
0.03
-
0.09
240.30%
0.09
1.44%
0.00
95.37%
0.03
521.20%
0.00
93.62%
0.00
196.00%
1.11
22,120.03%
0.00
99.84%
0.01
283.74%
0.00
95.47%
capex to revenue
-18.67
-
-0.16
99.16%
-544.67
345,627.78%
-1.19
99.78%
-0.29
75.19%
-0.01
97.65%
-0.03
365.11%
-0.84
2,489.33%
-0.00
99.84%
-0.00
138.92%
-0.00
47.43%
cash per share
77.67
-
105.97
36.43%
209.86
98.04%
207.22
1.26%
105.51
49.08%
93.16
11.70%
63.37
31.98%
31.04
51.02%
32.67
5.27%
12.91
60.50%
0.98
92.39%
days of inventory on hand
-5.23K
-
-571.84
89.06%
13.31
102.33%
112.11
742.12%
98.94
11.75%
304.09
207.35%
64.57
78.77%
109.41
69.46%
120.54
10.17%
602.93
400.21%
days payables outstanding
597.90
-
58.30
90.25%
40.11
31.20%
824.94
1,956.93%
427.66
48.16%
676.03
58.08%
114.30
83.09%
86.17
24.61%
46.31
46.25%
346.80
648.80%
days sales outstanding
12.99K
-
55.37
99.57%
26.77K
48,242.11%
1.78K
93.36%
139.19
92.17%
41.83
69.95%
70.55
68.68%
162.51
130.34%
138.43
14.82%
208.79
50.83%
184.09
11.83%
debt to assets
0.05
-
0.48
836.48%
0.48
0.52%
0.77
59.35%
0.03
95.97%
debt to equity
0.06
-
6.27
9,758.65%
9.89
57.85%
-2.53
125.62%
0.35
113.69%
dividend yield
earnings yield
-0.14
-
-0.09
35.75%
-0.15
59.27%
-0.22
48.81%
-0.51
130.49%
-0.31
39.56%
-0.24
22.33%
-0.29
20.61%
-0.95
231.90%
-6.83
617.57%
2.52
136.91%
enterprise value
61.76M
-
109.56M
77.41%
121.21M
10.64%
79.78M
34.18%
73.41M
7.99%
97.73M
33.14%
158.21M
61.88%
367.86M
132.52%
178.38M
51.51%
111.39M
37.55%
4.27M
96.16%
enterprise value over ebitda
-5.83
-
-10.64
82.38%
-5.82
45.32%
-2.76
52.61%
-1.62
41.31%
-2.53
56.69%
-3.89
53.56%
-6.73
72.90%
-2.83
57.92%
-3.22
13.69%
-0.15
95.48%
ev to operating cash flow
-7.32
-
-8.96
22.38%
-6.80
24.10%
-2.82
58.48%
-1.64
41.93%
-2.84
72.95%
-3.88
36.91%
-7.57
95.04%
-2.74
63.79%
-3.82
39.18%
-0.12
96.87%
ev to sales
5.15K
-
15.62
99.70%
40.40K
258,568.23%
789.94
98.04%
18.32
97.68%
11.69
36.19%
25.15
115.12%
5.72
77.27%
2.08
63.61%
1.80
13.34%
0.66
63.61%
free cash flow per share
-55.53
-
-61.58
10.90%
-70.24
14.07%
-88.89
26.55%
-104.93
18.04%
-60.47
42.37%
-54.21
10.35%
-106.62
96.68%
-56.02
47.46%
-18.98
66.12%
-5.52
70.93%
free cash flow yield
-0.12
-
-0.12
1.83%
-0.14
18.05%
-0.21
55.83%
-0.51
140.68%
-0.27
46.73%
-0.22
18.03%
-0.33
47.76%
-0.54
64.55%
-3.39
524.31%
-3.78
11.50%
graham net net
63.07
-
57.16
9.37%
123.87
116.71%
174.07
40.52%
80.83
53.56%
75.43
6.68%
47.16
37.48%
-116.50
347.01%
-88.13
24.35%
-100.29
13.79%
-1.44
98.57%
graham number
342.43
-
358.56
4.71%
609.47
69.98%
637.62
4.62%
490.71
23.04%
370.38
24.52%
321.29
13.25%
173.59
45.97%
129.89
25.17%
164.06
26.31%
5.14
96.86%
income quality
0.79
-
1.14
43.84%
0.85
25.97%
0.96
13.83%
0.98
2.17%
0.89
9.69%
0.96
8.51%
0.64
33.79%
0.67
4.35%
0.41
38.81%
-1.50
467.80%
intangibles to total assets
0.11
-
0.09
16.43%
0.09
0.06%
0.08
9.43%
0.09
12.22%
0.09
7.51%
0.23
167.99%
0.49
113.43%
0.40
18.90%
0.41
4.47%
0
100%
interest coverage
-769.43
-
-27.80
96.39%
-103.78
273.33%
-81.45
21.52%
-674.96
728.70%
-235.51
65.11%
-98.63
58.12%
-4.99
94.94%
-4.90
1.88%
-1.04
78.83%
-73.44
6,984.93%
interest debt per share
0.09
-
1.77
1,870.35%
0.77
56.74%
1.17
53.50%
0.18
85.03%
0.29
66.37%
5.63
1,824.56%
103.82
1,744.07%
89.74
13.57%
105.94
18.06%
0.18
99.83%
inventory turnover
-0.07
-
-0.64
814.46%
27.42
4,395.42%
3.26
88.13%
3.69
13.31%
1.20
67.46%
5.65
370.96%
3.34
40.99%
3.03
9.23%
0.61
80.01%
invested capital
0.06
-
6.27
9,758.65%
9.89
57.85%
-2.53
125.62%
0.35
113.69%
market cap
73.61M
-
115.45M
56.85%
142.73M
23.63%
133.57M
6.42%
89.86M
32.72%
126.74M
41.03%
183.42M
44.72%
310.26M
69.15%
120.04M
61.31%
8.67M
92.78%
9.46M
9.09%
net current asset value
10.19M
-
22.17M
117.69%
53.76M
142.44%
56.30M
4.73%
39.40M
30.03%
45.56M
15.65%
39.12M
14.15%
-95.88M
345.12%
-83.16M
13.27%
-121.37M
45.95%
-4.84M
96.01%
net debt to ebitda
1.12
-
0.57
48.89%
1.03
80.48%
1.86
79.96%
0.36
80.48%
0.75
107.46%
0.62
17.56%
-1.05
269.94%
-0.93
12.12%
-2.97
220.56%
0.18
105.95%
net income per share
-68.15
-
-49.47
27.41%
-76.13
53.89%
-92.00
20.85%
-104.00
13.04%
-68.00
34.62%
-57.76
15.06%
-92.73
60.54%
-98.27
5.98%
-38.27
61.06%
3.68
109.62%
operating cash flow per share
-54.09
-
-56.48
4.41%
-64.35
13.93%
-88.52
37.56%
-102.23
15.49%
-60.37
40.95%
-53.94
10.64%
-50.61
6.18%
-55.92
10.50%
-18.85
66.29%
-5.52
70.74%
payables turnover
0.61
-
6.26
925.65%
9.10
45.35%
0.44
95.14%
0.85
92.90%
0.54
36.74%
3.19
491.44%
4.24
32.65%
7.88
86.06%
1.05
86.65%
receivables turnover
0.03
-
6.59
23,356.91%
0.01
99.79%
0.21
1,405.42%
2.62
1,177.44%
8.73
232.77%
5.17
40.71%
2.25
56.59%
2.64
17.40%
1.75
33.70%
1.98
13.42%
research and ddevelopement to revenue
675
-
1.81
99.73%
5.92K
327,054.31%
249.91
95.78%
8.23
96.71%
2.97
63.86%
2.77
6.89%
0.26
90.75%
0.34
34.24%
0.12
65.76%
0.54
358.70%
return on tangible assets
-0.83
-
-0.41
50.90%
-0.35
14.97%
-0.43
24.24%
-0.87
102.91%
-0.68
22.28%
-0.76
12.24%
-0.96
26.28%
-1.04
8.27%
-0.64
39.11%
1.04
262.90%
revenue per share
0.08
-
32.39
41,997.50%
0.01
99.97%
0.32
2,821.59%
9.15
2,792.12%
14.64
60.04%
8.33
43.13%
67.04
705.07%
73.73
9.97%
39.92
45.86%
1.01
97.48%
roe
-0.89
-
-0.43
51.95%
-0.35
18.03%
-0.47
33.43%
-1.01
115.76%
-0.76
24.96%
-0.73
4.11%
-6.42
782.93%
-12.88
100.60%
1.22
109.50%
11.53
841.89%
roic
-0.92
-
-0.43
52.53%
-0.38
12.12%
-0.51
33.10%
-1.31
158.23%
-0.78
40.36%
-0.66
15.83%
-0.70
6.28%
-0.94
34.33%
-0.43
53.95%
-9.67
2,132.54%
sales general and administrative to revenue
223.67
-
0.57
99.74%
1.38K
240,869.63%
53.50
96.12%
2.00
96.26%
0.90
55.17%
1.82
103.26%
0.39
78.40%
0.89
126.56%
0.89
0.42%
shareholders equity per share
76.47
-
115.51
51.06%
216.86
87.74%
196.41
9.43%
102.91
47.61%
89.66
12.87%
79.43
11.41%
14.44
81.82%
7.63
47.17%
-31.26
509.72%
0.32
101.02%
stock based compensation to revenue
104.58
-
0.25
99.76%
454.67
181,818.54%
16.62
96.34%
0.56
96.64%
0.32
42.57%
0.48
50.21%
0.07
86.43%
0.12
82.39%
0.09
22.89%
tangible asset value
10.37M
-
22.40M
115.97%
54.02M
141.19%
56.61M
4.79%
39.78M
29.72%
45.87M
15.30%
43.08M
6.09%
-74.02M
271.83%
-62.77M
15.19%
-114.03M
81.66%
2.07M
101.81%
tangible book value per share
66.50
-
103.43
55.55%
194.98
88.51%
177.32
9.06%
90.84
48.77%
80.34
11.55%
57.02
29.03%
-77.10
235.22%
-53.96
30.01%
-73.65
36.48%
0.32
100.43%
working capital
10.19M
-
24.30M
138.55%
55.00M
126.33%
62.46M
13.57%
39.85M
36.20%
46.41M
16.47%
42.60M
8.21%
-2.74M
106.43%
7.68M
380.36%
-111.55M
1,552.15%
-3.10M
97.22%

All numbers in USD (except ratios and percentages)